α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction

α-Synuclein (αSyn) is a presynaptic protein of unestablished physiological function that plays a central role in Parkinson's disease neuropathology. To date, the reported effects of αSyn expression on the kinetics of axonal synaptic vesicle exocytosis and membrane cycling have been relatively small. In contrast, we report that αSyn is the major modulator of substantia nigra somatodendritic dopamine release, a little-understood form of neurotransmission that is central to sensorimotor and basal ganglia circuitry. This regulation is due to a previously unknown role for αSyn in controlling the activity of the L-type calcium ion channels (LTCC), which are also implicated in Parkinson's pathogenesis. αSyn-deficient neurons further display decreased spike frequency adaptation, hippocampal LTCC-dependent long-term potentiation, and immediate early gene induction, functions that are essential for synaptic adaptation and neuronal plasticity.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-01-28
DOI
https://doi.org/10.1126/sciadv.ady6978
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction

Nagendran Ramalingam, Eugene V. Mosharov, Ulf Dettmer, Ellen Kanter et al.
Science Advances
Parkinson's Disease Mechanisms and Treatments
article

α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction

Nagendran Ramalingam, Eugene V. Mosharov, Ulf Dettmer, Ellen Kanter, Guomei Tang, Se Joon Choi, Benjamin D. Hobson, Anika Frank, Manu Ben-Johny, Jonas Bendig, David Sulzer
article en

Abstract

α-Synuclein (αSyn) is a presynaptic protein of unestablished physiological function that plays a central role in Parkinson's disease neuropathology. To date, the reported effects of αSyn expression on the kinetics of axonal synaptic vesicle exocytosis and membrane cycling have been relatively small. In contrast, we report that αSyn is the major modulator of substantia nigra somatodendritic dopamine release, a little-understood form of neurotransmission that is central to sensorimotor and basal ganglia circuitry. This regulation is due to a previously unknown role for αSyn in controlling the activity of the L-type calcium ion channels (LTCC), which are also implicated in Parkinson's pathogenesis. αSyn-deficient neurons further display decreased spike frequency adaptation, hippocampal LTCC-dependent long-term potentiation, and immediate early gene induction, functions that are essential for synaptic adaptation and neuronal plasticity.

Science AdvancesVol. 12(5)
Brigham and Women's Hospital (US), Columbia University Irving Medical Center (US), New York Psychoanalytic Society and Institute (US)
York University, Deutsche Forschungsgemeinschaft
Good health and well-being
Openalex Percentile: Top 76%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction — Nagendran Ramalingam, Eugene V. Mosharov, et al. · Science Advances (2026) | TGRS Research Map | TGRS